A prospective study of cutaneous intolerance to topical mechlorethamine therapy in patients with cutaneous T-cell lymphomas
E Esteve, M Bagot, P Joly, P Souteyrand… - Archives of …, 1999 - jamanetwork.com
Objective To study the exact frequency and the histological features of cutaneous
intolerance to mechlorethamine (CIM) hydrochloride therapy in patients with cutaneous T-
cell lymphomas, including Langerhans cell histiocytosis. Design A multicenter prospective
study was conducted from January 1, 1994, to May 31, 1996, in 12 different hospitals in
France. Patients Of the 52 patients with cutaneous T-cell lymphomas or Langerhans cell
histiocytosis, 35 were men and 17 were women, aged 18 to 87 years. Of the 52 patients, 35 …
intolerance to mechlorethamine (CIM) hydrochloride therapy in patients with cutaneous T-
cell lymphomas, including Langerhans cell histiocytosis. Design A multicenter prospective
study was conducted from January 1, 1994, to May 31, 1996, in 12 different hospitals in
France. Patients Of the 52 patients with cutaneous T-cell lymphomas or Langerhans cell
histiocytosis, 35 were men and 17 were women, aged 18 to 87 years. Of the 52 patients, 35 …